전기의료 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Electroceuticals Market was valued at USD 22.8 billion in 2024 and is projected to grow at a CAGR of 6.6% between 2025 and 2034. The market is witnessing significant expansion, driven by technological advancements in bioelectronic medicine, increasing prevalence of chronic diseases, and rising demand for non-drug treatment alternatives. Electroceuticals, which leverage electrical stimulation to treat medical conditions, are gaining widespread attention as patients and healthcare providers seek more effective, minimally invasive therapies with fewer side effects compared to traditional pharmaceuticals. The growing burden of chronic conditions such as cardiovascular diseases, neurological disorders, and pain management challenges has fueled interest in these devices. As the healthcare industry shifts towards more patient-centric care, electroceuticals are emerging as a critical component of modern treatment approaches.

Innovations in bioelectronic medicine are enabling the development of more efficient and precise electroceutical devices, further propelling market growth. Increasing research investments and favorable regulatory policies are encouraging manufacturers to expand their product portfolios. Moreover, rising consumer awareness about non-invasive treatment options and improved accessibility to healthcare solutions are boosting adoption rates. With the integration of artificial intelligence and smart monitoring capabilities, electroceutical devices are becoming more personalized and effective in managing long-term conditions. The market is also benefiting from collaborations between medtech companies and research institutions, driving breakthroughs in device miniaturization, wireless communication, and battery life improvements.

The market is segmented based on product categories, including cardiac devices, neuromodulators, and implants. Cardiac devices, which include pacemakers and defibrillators, are expected to experience the highest growth, with a CAGR of 6.7%, reaching USD 18.9 billion by 2034. The increasing prevalence of cardiovascular diseases, coupled with an aging global population, is driving demand for these life-saving devices. Continuous improvements in cardiac technologies, such as MRI-compatible pacemakers and remote patient monitoring systems, are making these solutions more effective and accessible. The integration of AI-powered diagnostics and real-time health tracking is further enhancing their adoption in clinical settings.

The electroceuticals market is also classified into implantable and non-invasive devices. The implantable devices segment is projected to reach USD 34.3 billion by 2034, growing at a CAGR of 6.3%. Rising incidences of chronic diseases and ongoing advancements in bioelectronic medicine are key growth drivers. Implantable electroceuticals, such as spinal cord stimulators and cochlear implants, offer long-term solutions for managing conditions without continuous medication use, making them an attractive option for both patients and healthcare providers.

U.S. Electroceuticals Market generated USD 7.6 billion in 2024 and is forecasted to grow at a CAGR of 5.7% between 2025 and 2034. The increasing prevalence of chronic diseases, particularly cardiovascular and neurological disorders, is fueling demand for electroceutical solutions. A rapidly aging population and continuous advancements in medical technology are further supporting market growth. Pacemakers, deep brain stimulators, and other electroceutical devices are in high demand due to their proven efficacy in treating chronic pain, heart conditions, and neurological disorders. As healthcare infrastructure strengthens and reimbursement policies become more favorable, the U.S. electroceuticals market is poised for sustained expansion.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Advancements in bioelectronics and neurostimulation technologies
    • 3.2.1.2 Increasing adoption of minimally invasive procedures
    • 3.2.1.3 Rising demand for pain management solutions
    • 3.2.1.4 Expansion of applications in neurological and psychiatric disorders
    • 3.2.1.5 Growing investments in bioelectric medicine research
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of electroceutical devices
    • 3.2.2.2 Risk of device malfunction and safety concerns
    • 3.2.2.3 Availability of alternative treatment options
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Value chain analysis
• 3.11 Overview on clinically driven smart implantable electronic devices moving towards precision therapy

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiac pacemakers and implantable cardioverter defibrillators
• 5.3 Neuromodulators
  • 5.3.1 Spinal cord stimulators
  • 5.3.2 Deep brain stimulators
  • 5.3.3 Vagus nerve stimulators
  • 5.3.4 Sacral nerve stimulators
  • 5.3.5 Gastric electrical stimulators
  • 5.3.6 Transcutaneous electrical nerve stimulators
  • 5.3.7 Transcranial magnetic stimulators
  • 5.3.8 Other neuromodulators
• 5.4 Cochlear implants
• 5.5 Retinal implants

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Implantable devices
• 6.3 Non-invasive devices

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Arrhythmia
• 7.3 Chronic pain management
• 7.4 Neurological disorders
• 7.5 Hearing loss
• 7.6 Parkinson's disease
• 7.7 Urine incontinence
• 7.8 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Ambulatory surgical centers (ASCs)
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Abbott
• 10.2 Axonics
• 10.3 BIOTRONIK
• 10.4 Boston Scientific
• 10.5 Cala Health
• 10.6 Cochlear
• 10.7 LivaNova
• 10.8 Medico S.p.A.
• 10.9 Medtronic
• 10.10 MicroPort
• 10.11 Monarch
• 10.12 NEUROPACE
• 10.13 Nevro
• 10.14 Nurotron
• 10.15 SetPoint Medical
• 10.16 Sky Medical Technology
• 10.17 SONOVA